# FDA recall D-1079-2020

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2020-04-01.

## Product

Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01

## Reason for recall

Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.

## Distribution

U.S.A. Nationwide

## Key facts

- **Recall number:** D-1079-2020
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-04-01
- **Report date:** 2020-04-08
- **Termination date:** 2021-06-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1079-2020

## Citation

> AI Analytics. FDA recall D-1079-2020. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1079-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*